{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:50:05Z","timestamp":1787500205681,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n                      infections, including Invasive Pneumococcal Diseases (IPDs), pose a substantial public health challenge, causing significant morbidity and mortality, especially among children and older adults. Vaccination campaigns have played a vital role in reducing pneumococcal-related deaths. However, obstacles related to accessibility and awareness might impede optimal vaccine adoption. This study aims to provide comprehensive data on pneumococcal vaccine coverage and attitudes within at-risk groups in Italy, with the goal of informing public health strategies and addressing vaccination barriers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between April 11 and May 29, 2022, a questionnaire investigating vaccine uptake and attitudes toward several vaccinations was administered to 10,000 Italian adults, chosen through population-based sampling. Respondents who were targets of the campaign according to the 2017\u20132019 National Vaccination Plan, accessed questions regarding pneumococcal vaccination. Data on uptake, awareness of having the right to free vaccination, opinion on vaccine safety, concern with pneumococcal disease, and ease of access to vaccination services were summarized and presented based on statistical regions. Multinomial logistic regression analysis was used to explore factors influencing vaccine uptake.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Out of 2357 eligible adult respondents (42.6% women; mean age: 58.1\u2009\u00b1\u200915.7), 39.5% received pneumococcal vaccination. Uptake differed among at-risk groups: respondents aged \u226565 (33.7%), with lung disease (48.4%), cardiovascular disease (46.6%), and diabetes (53.7%). Predictors of not being vaccinated and unwilling to included female gender, residing in rural areas, lower education, low concern about pneumococcal disease, vaccine safety concerns, and associations with vaccine-opposed acquaintances. Health access issues predicted willingness to be vaccinated despite non-vaccination. Pneumopathy, heart disease, diabetes, and living in Northeastern or Central Italy were linked to higher uptake. Among the 1064 parents of eligible children, uptake was 79.1%. Parental unawareness of children\u2019s free vaccination eligibility was a predictor of non-vaccination. Vaccine safety concerns correlated with reluctance to vaccinate children, while perceived healthcare access challenges were associated with wanting but not having received vaccination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Pneumococcal vaccination uptake within prioritized groups and children in Italy remains inadequate. Scarce awareness of vaccine availability and obstacles in accessing vaccinations emerge as principal barriers influencing this scenario.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-024-18216-3","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T11:02:33Z","timestamp":1709809353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Pneumococcal vaccine uptake among high-risk adults and children in Italy: results from the OBVIOUS project survey"],"prefix":"10.1186","volume":"24","author":[{"given":"Zeno","family":"Di Valerio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusy","family":"La Fauci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Scognamiglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelia","family":"Salussolia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Montalti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Capodici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia","family":"Fantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Odone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Costantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Sold\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi J.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Leask","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Lenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Gori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the OBVIOUS board","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Capodici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Conversano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Costantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko Degli","family":"Esposti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeno","family":"Di Valerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia","family":"Fantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Gori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Grignolio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusy","family":"La Fauci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Leask","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Lenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Montalti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Odone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Remondini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Scognamiglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelia","family":"Salussolia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Sold\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"issue":"4","key":"18216_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/clinids\/14.4.801","volume":"14","author":"DM Musher","year":"1992","unstructured":"Musher DM. Infections caused by Streptococcus pneumoniae: clinical Spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis. 1992;14(4):801\u20139.\u00a0https:\/\/www.jstor.org\/stable\/4456413. Accessed 02 July 2023.","journal-title":"Clin Infect Dis"},{"key":"18216_CR2","volume-title":"Seattle, WA: Institute for Health Metrics and Evaluation (IHME)","author":"GBD 2019 Results","year":"2020","unstructured":"GBD 2019 Results. Seattle, WA: Institute for Health Metrics and Evaluation (IHME). 2020. https:\/\/vizhub.healthdata.org\/gbd-results\/. Accessed 02 July 2023 ."},{"key":"18216_CR3","volume-title":"Rapporto ISS Sorveglianza RIS-3\/2022 - Sorveglianza nazionale delle malattie batteriche invasive","author":"Istituto Superiore di Sanit\u00e0","year":"2022","unstructured":"Istituto Superiore di Sanit\u00e0. Rapporto ISS Sorveglianza RIS-3\/2022 - Sorveglianza nazionale delle malattie batteriche invasive. 2022. https:\/\/www.iss.it\/documents\/20126\/6703853\/RIS-3_2022.pdf\/6163051a-8f97-1b6b-4d9c-be2079b02eac?t=1674037787174. Accessed 02 July 2023 ."},{"key":"18216_CR4","volume-title":"Introduction of PCV (Pneumococcal conjugate vaccine)","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. Introduction of PCV (Pneumococcal conjugate vaccine). 2021. http:\/\/immunizationdata.who.int\/pages\/vaccine-intro-by-antigen\/pneumo_conj.html?ISO_3_CODE=&YEAR=&CODE=High%20income. Accessed 02 July 2023 ."},{"key":"18216_CR5","volume-title":"Introduction of PPV (Pneumococcal polysaccharide vaccine)","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. Introduction of PPV (Pneumococcal polysaccharide vaccine). 2021. http:\/\/immunizationdata.who.int\/pages\/vaccine-intro-by-antigen\/pneumo_ps.html?ISO_3_CODE=&YEAR=&CODE=High%20income. Accessed 02 July 2023 ."},{"issue":"1","key":"18216_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41479-022-00097-y","volume":"14","author":"DM Musher","year":"2022","unstructured":"Musher DM, Anderson R, Feldman C. The remarkable history of pneumococcal vaccination: an ongoing challenge. Pneumonia. 2022;14(1):5. https:\/\/doi.org\/10.1186\/s41479-022-00097-y.","journal-title":"Pneumonia."},{"key":"18216_CR7","volume-title":"Surveillance report - Invasive pneumococcal disease - Annual Epidemiological Report for 2018","author":"European Centre for Disease Prevention and Control","year":"2020","unstructured":"European Centre for Disease Prevention and Control. Surveillance report - Invasive pneumococcal disease - Annual Epidemiological Report for 2018. 2020. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/AER_for_2018_IPD.pdf. Accessed 02 July 2023 ."},{"key":"18216_CR8","volume-title":"PNEUMOVAX 23 - Pneumococcal Vaccine, Polyvalent | FDA","author":"U.S. Food and Drug Administration","year":"2021","unstructured":"U.S. Food and Drug Administration. PNEUMOVAX 23 - Pneumococcal Vaccine, Polyvalent | FDA. 2021. https:\/\/www.fda.gov\/vaccines-blood-biologics\/pneumovax-23-pneumococcal-vaccine-polyvalent. Accessed 02 July 2023 ."},{"key":"18216_CR9","volume-title":"Prevenar: pneumococcal polysaccharide conjugate vaccine","author":"European Medicines Agency","year":"2009","unstructured":"European Medicines Agency. Prevenar: pneumococcal polysaccharide conjugate vaccine. Amsterdam: European Medicines Agency; 2009. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/prevenar. Accessed 02 July 2023 ."},{"key":"18216_CR10","volume-title":"Prevenar 13: pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)","author":"European Medicines Agency","year":"2021","unstructured":"European Medicines Agency. Prevenar 13: pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed). Amsterdam: European Medicines Agency; 2021. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/prevenar-13. Accessed 02 July 2023 ."},{"key":"18216_CR11","volume-title":"Vaxneuvance: pneumococcal polysaccharide conjugate vaccine (15-valent, adsorbed)","author":"European Medicines Agency","year":"2021","unstructured":"European Medicines Agency. Vaxneuvance: pneumococcal polysaccharide conjugate vaccine (15-valent, adsorbed). Amsterdam: European Medicines Agency; 2021. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/vaxneuvance. Accessed 02 July 2023 ."},{"key":"18216_CR12","volume-title":"Apexxnar: pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)","author":"European Medicines Agency","year":"2023","unstructured":"European Medicines Agency. Apexxnar: pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed). Amsterdam: European Medicines Agency; 2023. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/apexxnar. Accessed 02 July 2023 ."},{"issue":"1","key":"18216_CR13","doi-asserted-by":"publisher","first-page":"e0169368","DOI":"10.1371\/journal.pone.0169368","volume":"12","author":"G Falkenhorst","year":"2017","unstructured":"Falkenhorst G, Remschmidt C, Harder T, Hummers-Pradier E, Wichmann O, Bogdan C. Effectiveness of the 23-Valent pneumococcal polysaccharide vaccine (PPV23) against pneumococcal disease in the elderly: systematic review and Meta-analysis. PLoS One. 2017;12(1):e0169368. https:\/\/doi.org\/10.1371\/journal.pone.0169368.","journal-title":"PLoS One"},{"issue":"8","key":"18216_CR14","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1093\/cid\/ciu524","volume":"59","author":"ZB Harboe","year":"2014","unstructured":"Harboe ZB, Dalby T, Weinberger DM, Benfield T, M\u00f8lbak K, Slotved HC, et al. Impact of 13-Valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality. Clin Infect Dis. 2014;59(8):1066\u201373. https:\/\/doi.org\/10.1093\/cid\/ciu524.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"18216_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1086\/648593","volume":"201","author":"T Pilishvili","year":"2010","unstructured":"Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010;201(1):32\u201341. https:\/\/doi.org\/10.1086\/648593.","journal-title":"J Infect Dis"},{"key":"18216_CR16","unstructured":"Ministero della Salute. Piano Nazionale Vaccini 2017\u20132019. https:\/\/www.epicentro.iss.it\/vaccini\/PianoNazionaleVaccini. Accessed 02 July 2023."},{"key":"18216_CR17","unstructured":"World Health Organization. Wkly Epidemiol Rec, 2021, 96, 20. https:\/\/www.who.int\/publications\/i\/item\/who-wer9720-209-224. Accessed 02 July 2023."},{"key":"18216_CR18","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.5548679","volume-title":"Behavioural and social drivers of vaccination: tools and practical guidance for achieving high uptake","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. Behavioural and social drivers of vaccination: tools and practical guidance for achieving high uptake. World health Organization; 2022. https:\/\/doi.org\/10.5281\/zenodo.5548679."},{"issue":"4","key":"18216_CR19","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3390\/vaccines11040839","volume":"11","author":"D Gori","year":"2023","unstructured":"Gori D, Capodici A, La Fauci G, et al. COVID-19 vaccine refusal and delay among adults in Italy: evidence from the OBVIOUS project, a National Survey in Italy. Vaccines. 2023;11(4):839. https:\/\/doi.org\/10.3390\/vaccines11040839.","journal-title":"Vaccines."},{"key":"18216_CR20","volume-title":"I tempi della vita quotidiana-lavoro, conciliazione, parit\u00e0 di genere e benessere soggettivo","author":"Istituto Nazionale di Statistica","year":"2023","unstructured":"Istituto Nazionale di Statistica. I tempi della vita quotidiana-lavoro, conciliazione, parit\u00e0 di genere e benessere soggettivo. 2023. https:\/\/www.istat.it\/it\/archivio\/230102. Accessed 02 July 2023 ."},{"key":"18216_CR21","volume-title":"Osservatorio Strategie Vaccinali: 1\u00b0 Rapporto Annuale","author":"CREA Sanit\u00e0","year":"2023","unstructured":"CREA Sanit\u00e0. Osservatorio Strategie Vaccinali: 1\u00b0 Rapporto Annuale. 2023. https:\/\/www.creasanita.it\/wp-content\/uploads\/2023\/03\/Osservatorio-Strategie-Vaccinali-1-Rapporto-Annuale-.pdf. Accessed 02 July 2023 ."},{"key":"18216_CR22","doi-asserted-by":"publisher","first-page":"571602","DOI":"10.3389\/fpubh.2020.571602","volume":"8","author":"KD Zens","year":"2020","unstructured":"Zens KD, Schmutz C, Schwenkglenks M, et al. Pneumococcal vaccination coverage and uptake among adults in Switzerland: a Nationwide cross-sectional study of vaccination records. Front Public Health. 2020;8:571602. https:\/\/doi.org\/10.3389\/fpubh.2020.571602.","journal-title":"Front Public Health"},{"issue":"11","key":"18216_CR23","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.medmal.2008.08.007","volume":"38","author":"AS Delelis-Fanien","year":"2008","unstructured":"Delelis-Fanien AS, Lasserre A, Pulcini C, et al. Vaccine coverage against influenza and pneumococcal infections in patients aged 65 and over: a survey on 299 outpatients [in French]. Med Mal Infect. 2008;38(11):589\u201394. https:\/\/doi.org\/10.1016\/j.medmal.2008.08.007.","journal-title":"Med Mal Infect"},{"issue":"1","key":"18216_CR24","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1186\/s12889-019-7568-x","volume":"19","author":"D Papazoglou","year":"2019","unstructured":"Papazoglou D, Kotsiou OS, Papadimitriou EK, et al. Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients. BMC Public Health. 2019;19(1):1243. https:\/\/doi.org\/10.1186\/s12889-019-7568-x.","journal-title":"BMC Public Health"},{"issue":"1","key":"18216_CR25","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1186\/s12889-019-8055-z","volume":"19","author":"PC Matthews","year":"2019","unstructured":"Matthews PC, Berenzon SK, Valadez JJ, et al. Pneumococcal vaccine coverage among individuals aged 18 to 64\u2009years old with underlying medical conditions in the UK: a retrospective database analysis. BMC Public Health. 2019;19(1):1692. https:\/\/doi.org\/10.1186\/s12889-019-8055-z.","journal-title":"BMC Public Health"},{"key":"18216_CR26","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/1471-2458-11-422","volume":"11","author":"O Ochoa-Gondar","year":"2011","unstructured":"Ochoa-Gondar O, Vila-Corcoles A, Rodriguez-Blanco T, et al. Antipneumococcal vaccination in Catalonian adults: vaccine coverages and adequacy to distinct guideline recommendations. BMC Public Health. 2011;11:422. https:\/\/doi.org\/10.1186\/1471-2458-11-422.","journal-title":"BMC Public Health"},{"issue":"11","key":"18216_CR27","doi-asserted-by":"publisher","first-page":"895","DOI":"10.4161\/hv.6.11.13132","volume":"6","author":"D Martinelli","year":"2010","unstructured":"Martinelli D, Fortunato F, Tafuri S, et al. Burden of hospitalizations for pneumococcal pneumonia in the Apulia region of Italy, 2006\u20132008: analysis of administrative databases and estimation of the vaccine effectiveness in the elderly population. Hum Vaccin. 2010;6(11):895\u2013900. https:\/\/doi.org\/10.4161\/hv.6.11.13132.","journal-title":"Hum Vaccin"},{"issue":"12","key":"18216_CR28","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1080\/21645515.2019.1661754","volume":"15","author":"S Bellino","year":"2019","unstructured":"Bellino S, Puro V, Fusco FM, et al. Influenza and pneumococcal immunization in Italian healthcare workers: a cross-sectional study on knowledge, attitudes and behaviors. Hum Vaccin Immunother. 2019;15(12):2874\u201381. https:\/\/doi.org\/10.1080\/21645515.2019.1661754.","journal-title":"Hum Vaccin Immunother"},{"key":"18216_CR29","volume-title":"Pneumococcal vaccination coverage","author":"WHO Regional Office for Europe","year":"2023","unstructured":"WHO Regional Office for Europe. Pneumococcal vaccination coverage. 2023. https:\/\/gateway.euro.who.int\/en\/indicators\/epw_29-pneumococcal-vaccination-coverage\/visualizations\/#id=36870&tab=table. Accessed 02 July 2023 ."},{"issue":"1","key":"18216_CR30","doi-asserted-by":"publisher","first-page":"2171185","DOI":"10.1080\/21645515.2023.2171185","volume":"19","author":"FP Bianchi","year":"2023","unstructured":"Bianchi FP, Stefanizzi P, Cuscianna E, Riformato G, Di Lorenzo A, Giordano P, et al. COVID-19 vaccination hesitancy among Italian parents: a systematic review and meta-analysis. Hum Vaccin Immunother. 2023;19(1):2171185.","journal-title":"Hum Vaccin Immunother."},{"issue":"6","key":"18216_CR31","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1513\/AnnalsATS.201511-778FR","volume":"13","author":"AC Berical","year":"2016","unstructured":"Berical AC, Harris D, Dela Cruz CS, Possick JD. Pneumococcal vaccination strategies. An update and perspective. Ann Am Thorac Soc. 2016;13(6):933\u201344. https:\/\/doi.org\/10.1513\/AnnalsATS.201511-778FR.","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"18216_CR32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/j.1469-0691.2010.03182.x","volume":"16","author":"J Linares","year":"2010","unstructured":"Linares J, Ardanuy C, Pallares R, Fenoll A. Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. Clin Microbiol Infect. 2010;16(5):402\u201310. https:\/\/doi.org\/10.1111\/j.1469-0691.2010.03182.x.","journal-title":"Clin Microbiol Infect"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-18216-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-024-18216-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-18216-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T11:03:18Z","timestamp":1709809398000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-024-18216-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["18216"],"URL":"https:\/\/doi.org\/10.1186\/s12889-024-18216-3","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,7]]},"assertion":[{"value":"13 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required under the Italian legislation on the subject of experimental research (\u201cGazzetta Ufficiale no. 76, 31\/03\/2008\u201d) as the present study did not conform to the definition of a clinical trial, and investigators only had access to fully anonymized data collected and provided to them by Dynata Italy, a survey company that operates under relevant Italian and European legislation on data protection. The study was conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"J.L. (Julie Leask) has received funding from the World Health Organization for research and consultancy. H.J.L. received a grant for the Vaccine Confidence Project from Merch, J&J, and GSK. The remaining authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"736"}}